Video

How the Pharmacy Profession Will Change

Joe DiPiro, PharmD, president-elect of the American Association of Colleges of Pharmacy (AACP) and dean of the Virginia Commonwealth University (VCU) School of Pharmacy, predicts how the pharmacy profession will continue to change.

Joe DiPiro, PharmD, president-elect of the American Association of Colleges of Pharmacy (AACP) and dean of the Virginia Commonwealth University (VCU) School of Pharmacy, predicts how the pharmacy profession will continue to change.

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Subscribe Now!
Related Videos
Washington D.C., USA - March 1, 2020: American Institute of Pharmacy Building in Washington, D.C., United States, the first-established professional society of pharmacists in the United States.
American Captial Building.
Related Content
Doctor measuring overweight boy in clinic - Image credit: Africa Studio | stock.adobe.com
September 4th 2025

Fitness, Lean Mass Linked to Reduced Anxiety and Depression in Children

Kennedy Ferruggia, Assistant Editor
Pharmacy Focus Oncology Edition Podcast
September 4th 2025

Protecting Community Oncology Practices in the Wake of the IRA

Alexandra Gerlach, Associate Editor
Clogged arteries, Cholesterol plaque in artery. 3d illustration - Image credit: Rasi | stock.adobe.com
September 4th 2025

Enlicitide Offers a New Oral Option for Managing High Cholesterol

Kennedy Ferruggia, Assistant Editor
From Guidelines to Action: Pharmacy’s Role in Hypertension Management
September 4th 2025

From Guidelines to Action: Pharmacy’s Role in Hypertension Management

Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPSAQ Cardiology, CACP Aislinn Antrim, Managing Editor
Close up Hand doctor point MRA brian scan image of a recent traumatic brain injury patient showing brain contusion and hemorrhage.Medical image concept. | Image Credit: Richman Photo | stock.adobe.com
September 4th 2025

Moderate-to-Severe TBI Linked to Elevated Risk of Malignant Brain Tumors

Danielle Valletti, Assistant Editor
FDA waives clinical efficacy studies for certain biosimilars -- Image credit: Kamitana | stock.adobe.com
September 4th 2025

FDA to Waive Clinical Efficacy Studies for Monoclonal Antibody Biosimilars

Gillian McGovern, Associate Editor
© 2025 MJH Life Sciences

All rights reserved.